This session will discuss the pathophysiology, diagnostic options and therapeutic options for commonly encountered causes of secondary dilated cardiomyopathy phenotypes in dogs. Following this session, participants should be:
• Familiar with current terminology and sources of information related to the most commonly encountered causes of dilated cardiomyopathy phenotypes in dogs
• Able to describe the most commonly encountered non-inherited etiologies that cause dilated cardiomyopathy phenotypes in dogs
• Able to recognize the clinicopathologic findings most commonly associated with dilated cardiomyopathy phenotypes due to various non-inherited etiologies in dogs
• Able to generate appropriate diagnostic plans to document and characterize dilated cardiomyopathy phenotypes due to various non-inherited etiologies in dogs
• Familiar with the therapeutic options available for treating dilated cardiomyopathy phenotypes due to various non-inherited etiologies in dogs
Recording from 7 July 2022
Speaker:
Michael Aherne
Dr. Michael Aherne, MVB (Hons 1), GradDipVetStud, MS, MANZCVS (Small Animal Surgery), DACVIM (Cardiology)